| dc.contributor.author | Sharkey, Jack | |
| dc.contributor.author | Starkey Lewis, Philip J. | |
| dc.contributor.author | Barrow, Michael | |
| dc.contributor.author | Alwahsh, Salamah M | |
| dc.contributor.author | Forbes, Shareen | |
| dc.contributor.author | Forbes, Stuart J. | |
| dc.contributor.author | Park, B Kevin | |
| dc.date.accessioned | 2021-05-04T08:00:05Z | |
| dc.date.accessioned | 2022-05-22T08:54:12Z | |
| dc.date.available | 2021-05-04T08:00:05Z | |
| dc.date.available | 2022-05-22T08:54:12Z | |
| dc.date.issued | 2017-04 | |
| dc.identifier.uri | https://pubmed.ncbi.nlm.nih.gov/28214127/ | |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/8234 | |
| dc.description.abstract | Background aims: Tracking cells during regenerative cytotherapy is crucial for monitoring their safety and efficacy. Macrophages are an emerging cell-based regenerative therapy for liver disease and can be readily labeled for medical imaging. A reliable, clinically applicable cell-tracking agent would be a powerful tool to study cell biodistribution. Methods: Using a recently described chemical design, we set out to functionalize, optimize and characterize a new set of superparamagnetic iron oxide nanoparticles (SPIONs) to efficiently label macrophages for magnetic resonance imaging-based cell tracking in vivo. Results: A series of cell health and iron uptake assays determined that positively charged SPIONs (+16.8 mV) could safely label macrophages more efficiently than the formerly approved ferumoxide (-6.7 mV; Endorem) and at least 10 times more efficiently than the clinically approved SPION ferumoxytol (-24.2 mV; Rienso). An optimal labeling time of 4 h at 25 µg/mL was demonstrated to label macrophages of mouse and human origin without any adverse effects on cell viability whilst providing substantial iron uptake (>5 pg Fe/cell) that was retained for 7 days in vitro. SPION labeling caused no significant reduction in phagocytic activity and a shift toward a reversible M1-like phenotype in bone marrow-derived macrophages (BMDMs). Finally, we show that SPION-labeled BMDMs delivered via the hepatic portal vein to mice are localized in the hepatic parenchyma resulting in a 50% drop in T2* in the liver. Engraftment of exogenous cells was confirmed via immunohistochemistry up to 3 weeks posttransplantation. | en_US |
| dc.description.sponsorship | UK Regenerative Medicine Platform Safety and Efficacy Hub (grant ref MR/K026739/1) | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | MRI; cell therapy; cell tracking; liver fibrosis; macrophage. | en_US |
| dc.title | Functionalized superparamagnetic iron oxide nanoparticles provide highly efficient iron-labeling in macrophages for magnetic resonance– based detection in vivo | en_US |
| dc.type | Article | en_US |